Risk Factors and Prevention of Severe Pain Upon Cessation of a Peripheral Nerve Block
NCT04890418
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Surgery
Interventions
DRUG:
Ketalar, 5 mg/mL Injectable Solution
OTHER:
Placebo
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain